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Abstract 
The aim of this study is to assess the preva-
lence of isolated short stature as a clinical pres-
entation of celiac disease in Saudi Arab chil-
dren and whether some of the routine labora-
tory tests performed to determine the cause of
short  stature  could  suggest  the  diagnosis  of
celiac disease. A total of 91 children with short
stature were included in the study. Extensive
endocrine  and  biochemical  assessments,
including total protein, serum albumin, calci-
um  phosphate  and  alkaline  phosphatase
assays; renal function tests; coagulation pro-
file; anti-endomysial antibodies and anti-tissue
transglutaminase  antibody,  growth  hormone,
thyroid  stimulating  hormone,  free-thyroxin
(FT4) assays; stool tests for giardiasis; bone
age; and endoscopic intestinal biopsies, were
done for all children. Ten of the 91 children had
positive intestinal biopsies in the form of total
villous atrophy, an increase in crypt height, and
an  increase  in  intra-epithelial  lymphocyte
(IEL) numbers up to >40 IEL/100 EC (Type 3C)
according to the Oberhuber classification, con-
firming  the  diagnosis  of  celiac  disease.  Five
children had mild villous atrophy according to
this  classification  (Type  3A),  and  they  were
considered  to  have  potential  celiac  disease.
Seventy-six  children  had  normal  intestinal
biopsies.  Therefore,  the  prevalence  of  celiac
disease  among  Saudi  children  with  short
stature was 10.9%, and 4.3% of the children
were diagnosed as having potential celiac dis-
ease. After confirming the diagnosis of celiac
disease, all children were kept on a gluten-free
diet and all of them showed improvement in
their growth rate. We concluded that celiac dis-
ease is a very important cause of short stature
in children without gastrointestinal complaints
in Saudi Arabia. We highly recommend anti-tis-
sue  transglutaminase  and  anti-endomysial
antibody  screening  tests,  and  a  small  bowel
biopsy to confirm the diagnosis of celiac dis-
ease irrespective of the results of the antibody
assays, in children with short stature in Saudi
Arabia. Once the diagnosis is confirmed, chil-
dren should be kept on a gluten-free diet so
they can catch up their growth early before they
develop permanent short stature.
Introduction
Celiac disease (CD) is a permanent intoler-
ance  to  ingested  gluten  that  results  in
immunologically mediated inflammatory dam-
age to the small intestinal mucosa. CD must
always be considered when dealing with chil-
dren  manifesting  growth  failure.  The  preva-
lence of CD among children with short stature
in  Europe  is  approximately  0.05-0.2%  of  the
general population, reaching 1 in 300 in west-
ern Ireland. In Italy the prevalence is 59.1%
1
whereas in Spain it is 0.56%
2 and in western
New York 4.0%.
3 There has been no study con-
ducted  to  assess  its  prevalence  in  children
with short stature in Saudi Arabia.
Classically  infants  with  CD  present  with
impaired growth, diarrhea, and abdominal dis-
tension. Usually atypical presentation is seen
in older children, who often have no overt fea-
tures of malabsorption.
4 Extra-intestinal mani-
festations  such  as  short  stature,  delayed
puberty, dental enamel defects, and arthralgia
may occur as a monosymptomatic manifesta-
tion.
5 The diagnosis of CD was based on clini-
cal symptoms, positive antibodies, and a small
bowel biopsy.
6,7Histological evidence of CD was
reported according to the Oberhuber classifi-
cation.
8
Our aim in the present study is to assess the
prevalence of CD among Saudi children with
short  stature  who  have  no  gastrointestinal
symptoms,  and  to  determine  whether  celiac
serology can detect all cases of CD or if an
intestinal biopsy should be performed for any
case of short stature.     
Materials and Methods
A total of 91 children with a height less than
the 5
thcentile adjusted for their age and gender
were studied. All children were followed up in
the Department of Pediatrics at King Khalid
University Hospital from the period of August
2002 to December 2008. Any child with gas-
trointestinal symptoms was excluded from the
study.  All  children  with  etiological  factors
known to produce growth failure had also been
excluded;  for  example  chromosomal  anom-
alies, fetal growth failure, and chronic illness-
es. Selection criteria are shown in Table 1.  
All  children  had  undergone  an  extensive
endocrine work-up that included growth hor-
mone (GH), free-thyroxin (FT4), thyroid stim-
ulating hormone (TSH), glucose, electrolytes,
venous blood gas, and urine pH assessments.
The routine GH stimulation test using two bio-
chemical  (either  clonidine  and  glucagon  or
insulin-induced  hypoglycemia  as  a  secreta-
gogue)  and  two  physiological  (post-exercise
and during sleep) assessments was performed.
Patients were considered not to be GH defi-
cient when the peak GH value during the stim-
ulation test or the physiological test was >10
ng/dL.  Other  routine  investigations,  such  as
hemoglobin level [MCV, MCHC, total protein,
serum albumin, coagulation profile, calcium,
phosphorous,  and  alkaline  phosphatase
(ALP)] were done. Stool investigations for giar-
diasis were done for all patients. Bone age was
determined using the Greulich and Pyle atlas.
9
Pubertal  stages  were  evaluated  according  to
Tanner.
10 Mid-parental  height  was  calculated
for  each  child’s  parents  to  exclude  genetic
causes of short stature, using the standard for-
mula.
11
Anti-endomysial  and  anti-tissue  transglut-
aminase  screening  tests  for  CD  were  per-
formed  for  the  patients.  When  no  cause  of
short stature was found, upper digestive endos-
copies and small bowel biopsies was done for
all children. The biopsy specimens were taken
from the third part of the duodenum.
The results of the children’s heights before
and after the gluten-free diet were expressed
as a z-score.  
Results
Ten of the ninety-one patients had a positive
endoscopic intestinal biopsy with an increase
in  the  crypt  height  and  increase  in  intra-
epithelial lymphocyte (IEL) numbers up to >40
IEL/100EC,  Type  3C,  according  to  the
Oberhuber  classification,  indicating  CD
(group 1; N=10). Seventy-six children had a
normal endoscopic intestinal biopsy, and five
had mild villous atrophy with normal crypts,
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Type 3A according to this classification, and
were considered to have potential CD (Group
2;  N=5).  Therefore,  the  prevalence  of  well-
diagnosed CD among children of short stature
in this study was 10.9% while 4.3% was diag-
nosed as having potential CD.
CD in our study affected six males and four
females,  thus  the  prevalence  was  equal  in
males  and  females.  The  mean  values  for
chronological age, height, weight, bone age, as
well as pubertal stage were not significantly
different between patients with CD and non-
celiacs (P>0.05). The results of serum calci-
um,  phosphate,  alkaline  phosphatase,  total
protein, albumin assays, and hormonal tests
were also not significantly different. Tests for
celiac  antibodies  (anti-endomysial  and  anti-
tissue transglutaminase) were done for all the
patients and were strongly positive for ten chil-
dren,  who  were  confirmed  histologically  to
have CD, Type 3C. Five patients were IgG posi-
tive for anti-endomysial antibody, shown histo-
logically to be Type 3A.  
All children diagnosed to have CD and poten-
tial CD were kept on a gluten-free diet. Patients
were followed-up every six months and showed
improvement in growth rate. Four of them had
complete catch-up in growth after one year on
a  gluten-free  diet  (Table  2).  The  z-score  for
height before diagnosis was 2.14011±1.67487
while it was 1.84149±1.83677 one year after
starting the gluten-free diet.
Table 2 shows age, gender, serology, histol-
ogy, and height of children at the initial pres-
entation and on follow-up of height one year
on the gluten-free diet, as a z-score.
Discussion
This series shows a significant number of
cases  of  CD  and  potential  CD  (10.9%  and
4.3%)  among  Saudi  children  with  short
stature, who do not have underlying causes for
their short statures. The prevalence of CD in
children with short stature has been studied
in  different  regions  of  the  world.  It  ranged
from 0.05-59.1% depending on the region of
the  study.
1,3 In  reviewing  the  literature  we
found no single parameter suggestive of CD in
children with short-stature.
12-15 This supports
our data in this study.
None  of  the  biochemical  and  hormonal
measurements  was  positive  in  our  patients.
The pathogenesis of short stature as a mono-
symptomatic  manifestation  in  children  with
CD is not known. A review of the literature
showed that there are reasons to suggest that
nutritional deficiencies can result in growth
failure associated with changes in hormonal
status.
1 The hormonal abnormalities in these
data included low levels of insulin-like growth
factor-1 (IGF-I), which occurs after prolonged
exposure to gluten, and poor growth hormone
release in stimulatory tests.
16 Other endocrine
abnormalities that can occur in CD included
secondary hypopituitarism probably caused by
severe malnutrition and mainly found in long-
standing  CD,  hypogonadism  and  delayed
puberty,  reversed  insensitivity  to  androgens,
elevated  plasma  testosterone,  free  testos-
terone  index,  and  raised  plasma  luteinizing
hormone.
1,17 All children included in our study
had no gastrointestinal symptoms or malnutri-
tion  and  GH  and  thyroid  hormone  secretion
were normal.
The ultimate adult height will improve if the
treatment  of  CD  is  started  early;  however,
there will be a slight negative effect of the dis-
ease on growth.
18 Most of our children in this
study  who  were  followed  up  after  one  year
showed an increase in their heights. Height
and  weight  velocities  had  their  maximum
rates during the first year after initiation of
the gluten-free diet, but the catch-up growth
was  incomplete  over  three  years,  the  final
height seemingly influenced mainly by familial
characteristics.
18
We concluded that CD is prevalent among
Saudi children with short stature. The fact that
there was no difference between CD and non-
CD clinical, biochemical, and hormonal tests
indicates  that  it  is  important  to  do  anti-
endomysial and anti-tissue transglutaminase
antibody tests to investigate all children with
short stature for CD. In addition, it is impor-
tant to do a small bowel biopsy for children
with short stature, irrespective of the result of
celiac serology, in Saudi Arabia and all over the
world.
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